Hemoglobin A1c Testing Devices Market Size, Share, and Trends 2025 to 2034

The global hemoglobin A1c testing devices market size is calculated at USD 2.52 billion in 2025 and is forecasted to reach around USD 4.46 billion by 2034, accelerating at a CAGR of 6.52% from 2025 to 2034. The North America market size surpassed USD 1.02 billion in 2024 and is expanding at a CAGR of 6.64% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

Last Updated : June 2025  |  Report Code : 6287  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Hemoglobin A1c Testing Devices Market 

5.1. COVID-19 Landscape: Hemoglobin A1c Testing Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Hemoglobin A1c Testing Devices Market, By Type of Device

8.1. Hemoglobin A1c Testing Devices Market Revenue and Volume, by Type of Device

8.1.1 Laboratory-based testing devices

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Point-of-care (POC) testing devices

8.1.2.1. Market Revenue and Volume Forecast

Chapter 9. Global Hemoglobin A1c Testing Devices Market, By Technology

9.1. Hemoglobin A1c Testing Devices Market Revenue and Volume, by Technology

9.1.1. Immunoassays

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Chromatography

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Enzymatic assays

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Boronate affinity chromatography

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. High-performance liquid chromatography

9.1.5.1. Market Revenue and Volume Forecast

9.1.6. Others

9.1.6.1. Market Revenue and Volume Forecast

 

 

Chapter 10. Global Hemoglobin A1c Testing Devices Market, By End-User

10.1. Hemoglobin A1c Testing Devices Market Revenue and Volume, by End-User

10.1.1. Hospitals & clinics

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Diagnostic laboratories

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Homecare settings

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global Hemoglobin A1c Testing Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Type of Device

11.1.2. Market Revenue and Volume Forecast, by Technology

11.1.3. Market Revenue and Volume Forecast, by End-User

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Type of Device

11.1.4.2. Market Revenue and Volume Forecast, by Technology

11.1.4.3. Market Revenue and Volume Forecast, by End-User

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Type of Device

11.1.5.2. Market Revenue and Volume Forecast, by Technology

11.1.5.3. Market Revenue and Volume Forecast, by End-User

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Type of Device

11.2.2. Market Revenue and Volume Forecast, by Technology

11.2.3. Market Revenue and Volume Forecast, by End-User

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Type of Device

11.2.4.2. Market Revenue and Volume Forecast, by Technology

11.2.4.3. Market Revenue and Volume Forecast, by End-User

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Type of Device

11.2.5.2. Market Revenue and Volume Forecast, by Technology

11.2.5.3. Market Revenue and Volume Forecast, by End-User

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Type of Device

11.2.6.2. Market Revenue and Volume Forecast, by Technology

11.2.6.3. Market Revenue and Volume Forecast, by End-User

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Type of Device

11.2.7.2. Market Revenue and Volume Forecast, by Technology

11.2.7.3. Market Revenue and Volume Forecast, by End-User

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Type of Device

11.3.2. Market Revenue and Volume Forecast, by Technology

11.3.3. Market Revenue and Volume Forecast, by End-User

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Type of Device

11.3.4.2. Market Revenue and Volume Forecast, by Technology

11.3.4.3. Market Revenue and Volume Forecast, by End-User

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Type of Device

11.3.5.2. Market Revenue and Volume Forecast, by Technology

11.3.5.3. Market Revenue and Volume Forecast, by End-User

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Type of Device

11.3.6.2. Market Revenue and Volume Forecast, by Technology

11.3.6.3. Market Revenue and Volume Forecast, by End-User

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Type of Device

11.3.7.2. Market Revenue and Volume Forecast, by Technology

11.3.7.3. Market Revenue and Volume Forecast, by End-User

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Type of Device

11.4.2. Market Revenue and Volume Forecast, by Technology

11.4.3. Market Revenue and Volume Forecast, by End-User

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Type of Device

11.4.4.2. Market Revenue and Volume Forecast, by Technology

11.4.4.3. Market Revenue and Volume Forecast, by End-User

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Type of Device

11.4.5.2. Market Revenue and Volume Forecast, by Technology

11.4.5.3. Market Revenue and Volume Forecast, by End-User

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Type of Device

11.4.6.2. Market Revenue and Volume Forecast, by Technology

11.4.6.3. Market Revenue and Volume Forecast, by End-User

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Type of Device

11.4.7.2. Market Revenue and Volume Forecast, by Technology

11.4.7.3. Market Revenue and Volume Forecast, by End-User

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Type of Device

11.5.2. Market Revenue and Volume Forecast, by Technology

11.5.3. Market Revenue and Volume Forecast, by End-User

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Type of Device

11.5.4.2. Market Revenue and Volume Forecast, by Technology

11.5.4.3. Market Revenue and Volume Forecast, by End-User

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Type of Device

11.5.5.2. Market Revenue and Volume Forecast, by Technology

11.5.5.3. Market Revenue and Volume Forecast, by End-User

Chapter 12. Company Profiles

12.1. Bio-Rad Laboratories, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Abbott

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. F. Hoffmann-La Roche Ltd

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Siemens Healthineers AG

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. HUMAN

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Trinity Biotech

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Menarini Diagnostics s.r.l

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. SAKAE CO., LTD.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Ceragem Medisys Inc

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. SEKISUI MEDICAL CO., LTD.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global hemoglobin A1c testing devices market is expected to increase from USD 2.37 billion in 2024 to USD 4.46 billion by 2034.

The hemoglobin A1c testing devices marketis expected to grow at a compound annual growth rate (CAGR) of around 6.52% from 2025 to 2034.

The major players in the hemoglobin A1c testing devices market include Bio-Rad Laboratories, Inc., Abbott, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, HUMAN, Trinity Biotech, Menarini Diagnostics s.r.l, SAKAE CO., LTD., Ceragem Medisys Inc, and SEKISUI MEDICAL CO., LTD.

The driving factors of the hemoglobin A1c testing devices market are the rising popularity of telehealth and increased focus on self-monitoring are boosting the demand for at-home HbA1c testing devices.

North America region will lead the global hemoglobin A1c testing devices market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client